Toronto Dominion Bank
EW icon

Toronto Dominion Bank’s Edwards Lifesciences EW Stock Holding History

Toronto Dominion Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-153,300
Closed -$9.44M – 1518
2019
Q2 		$9.44M Buy
+153,300
New +$9.27M 0.02% 489

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Toronto Dominion Bank's EW Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Edwards Lifesciences (EW) stake by 18% in Q2 2026, selling an estimated $3.27M and leaving 174,321 shares worth $15.8M. The position accounts for 0.02% of the portfolio, ranked #559.

Toronto Dominion Bank first reported a position in EW in Q4 2013 and has held it in 51 quarters since. The position peaked at $73.6M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Toronto Dominion Bank held 174,321 shares of Edwards Lifesciences worth $15.8M as of Q2 2026.
  • Toronto Dominion Bank sold 39,052 Edwards Lifesciences shares in Q2 2026, an estimated $3.27M.
  • Edwards Lifesciences made up 0.02% of Toronto Dominion Bank's portfolio in Q2 2026, its #559 holding.
  • Toronto Dominion Bank first reported a position in Edwards Lifesciences in Q4 2013 and has held it in 51 quarters since.
  • Toronto Dominion Bank's Edwards Lifesciences position peaked at $73.6M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.